5 stories found
The World Health Organization (WHO) has initiated the first clinical trial for an antiviral medication specifically designed to prevent the Bundibugyo strain of Ebola. This marks a significant step in combating this particular variant of the virus.
The World Health Organization (WHO) has elevated the risk assessment for the Ebola outbreak in the Democratic Republic of Congo to 'very high' due to its rapid spread. The UN has allocated $60 million and is deploying staff to assist with the escalating crisis.
Clinical trials have commenced in the Democratic Republic of Congo, focusing on the Bundibugyo strain of Ebola. The trials are taking place in the epicenter of the outbreak, marking a significant step in combating the disease.
WHO declares global emergency over rare Bundibugyo Ebola strain MSN
India has developed and is implementing RT-PCR tests specifically designed to detect the Bundibugyo strain of the Ebola virus, enhancing its diagnostic capabilities for this particular variant.